facebook
Pintrest
The DRDO's (Defence Research and Development Organisation) newly launched anti-COVID medicine, 2-deoxy-D-glucose is being hailed as an innovative holy grail for COVID patients in India right now, who are currently battling for their lives and scouring for oxygen amidst a deadly grasp of the second wave of infections.
The innovative therapeutic drug, which has been launched for use today (May 17) is also said to hasten recovery timelines. But how effective is it really? Can all COVID-19 patients take it? Here's a brief explainer on the same.
What do we know about the drug, 2-deoxy-D-glucose?
2-deoxy-D-glucose is the first-ever 'fully homegrown' anti-COVID medicine which has been developed in India. According to researchers, it is one of the first therapeutic COVID-19 drugs which works to stop viral growth in the body, reduce the need for external oxygen.

Related Keywords

Delhi , India , Hyderabad , Andhra Pradesh , Telangana , , Development Organisation , Institute Of Nuclear Medicine , Defence Research , Nuclear Medicine , Allied Sciences , Drugs Controller General , West Bengal , Drdo Covid Drug Launches , Drdo Covid Drug , Coronavirus Symptoms Hospitalization , Coronavirus Symptoms , Coronavirus Infection , Coronavirus 2dg Drug , Anti Covid Drug , 2dg Drug , 2 Deoxyd Glucose , டெல்ஹி , இந்தியா , ஹைதராபாத் , ஆந்திரா பிரதேஷ் , தெலுங்கானா , வளர்ச்சி ஆர்கநைஸேஶந் , நிறுவனம் ஆஃப் அணு மருந்து , பாதுகாப்பு ஆராய்ச்சி , அணு மருந்து , கூட்டணி அறிவியல் , மருந்துகள் கட்டுப்படுத்தி ஜநரல் , மேற்கு பெங்கல் ,